$AHCO
AdaptHealth Corp. Stock $ahco

$ahco Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000155837022002603 Filed on March 01, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$702.1M	$2.455B	$362.7M
YoY Change	93.58%	132.35%	-31.51%
Cost Of Revenue	$578.6M	$2.009B	$288.9M
YoY Change	100.26%	123.56%	-34.43%
Gross Profit	$123.6M	$445.6M	$73.80M
YoY Change	67.42%	182.41%	-17.17%
Gross Profit Margin	17.6%	18.15%	20.35%
Selling, General & Admin	$47.99M	$234.6M	$36.50M
YoY Change	31.48%	110.58%	-31.39%
% of Gross Profit	38.84%	52.64%	49.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$111.6M	$258.1M	$24.50M
YoY Change	355.42%	213.0%	690.32%
% of Gross Profit	90.31%	57.91%	33.2%
Operating Expenses	$65.07M	$297.7M	$41.50M
YoY Change	56.8%	142.42%	-26.29%
Operating Profit	$58.48M	$225.6M	$32.30M
YoY Change	81.07%	216.21%	-1.52%
Interest Expense	-$29.79M	$95.20M	-$145.5M
YoY Change	-79.53%	129.77%	185.85%
% of Operating Profit	-50.94%	42.2%	-450.46%
Other Income/Expense, Net	-$5.795M	-$1.832M	-$98.70M
YoY Change	-94.13%	-153.19%	3848.0%
Pretax Income	$33.49M	$191.0M	-$211.9M
YoY Change	-115.81%	-192.68%	833.48%
Income Tax	$10.02M	$32.81M	-$14.20M
% Of Pretax Income	29.93%	17.18%
Net Earnings	$22.94M	$156.2M	-$163.0M
YoY Change	-114.07%	-196.62%	665.26%
Net Earnings / Revenue	3.27%	6.36%	-44.94%
Basic Earnings Per Share		$1.12
Diluted Earnings Per Share	$68.98K	$0.67	-$2.470M
COMMON SHARES
Basic Shares Outstanding	132.2M	126.3M
Diluted Shares Outstanding		133.0M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$149.6M	$149.6M	$100.0M
YoY Change	49.63%	49.63%	30.04%
Cash & Equivalents	$149.6M		$99.96M
Short-Term Investments		$14.00K
Other Short-Term Assets	$37.44M	$37.44M	$33.40M
YoY Change	12.1%	12.1%	162.99%
Inventory	$123.1M	$123.1M	$58.78M
Prepaid Expenses
Receivables	$359.9M	$359.9M	$171.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$670.1M	$670.1M	$363.3M
YoY Change	84.46%	84.44%	100.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$398.6M	$546.3M	$110.5M
YoY Change	260.81%	394.42%	73.8%
Goodwill	$3.513B		$998.8M
YoY Change	251.68%		274.38%
Intangibles	$202.2M		$116.1M
YoY Change	74.25%
Long-Term Investments
YoY Change
Other Assets	$15.10M	$319.3M	$16.48M
YoY Change	-8.4%	41.97%	140.59%
Total Long-Term Assets	$4.580B	$4.580B	$1.450B
YoY Change	215.84%	215.85%	297.19%
TOTAL ASSETS
Total Short-Term Assets	$670.1M	$670.1M	$363.3M
Total Long-Term Assets	$4.580B	$4.580B	$1.450B
Total Assets	$5.250B	$5.250B	$1.813B
YoY Change	189.53%	189.52%	231.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$248.0M	$248.0M	$191.0M
YoY Change	29.83%	29.86%	141.1%
Accrued Expenses	$95.89M	$95.89M	$37.80M
YoY Change	153.68%	153.68%
Deferred Revenue	$31.37M		$11.04M
YoY Change	184.07%		15.56%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$20.00M	$35.45M	$8.146M
YoY Change	145.52%	16.6%	373.33%
Total Short-Term Liabilities	$499.8M	$499.8M	$422.1M
YoY Change	18.42%	18.41%	173.97%
LONG-TERM LIABILITIES
Long-Term Debt	$2.184B	$2.184B	$776.6M
YoY Change	181.18%	180.9%	96.54%
Other Long-Term Liabilities	$322.5M	$500.3M	$186.5M
YoY Change	72.94%	50.19%	535.03%
Total Long-Term Liabilities	$2.506B	$2.684B	$963.0M
YoY Change	160.22%	141.69%	126.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$499.8M	$499.8M	$422.1M
Total Long-Term Liabilities	$2.506B	$2.684B	$963.0M
Total Liabilities	$3.184B	$3.189B	$1.533B
YoY Change	107.73%	118.61%	162.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$43.02M		-$199.2M
YoY Change	-78.4%		580.41%
Common Stock	$13.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.062B	$2.062B	$354.9M
YoY Change
Total Liabilities & Shareholders Equity	$5.250B	$5.250B	$1.813B
YoY Change	189.53%	189.52%	231.81%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$22.94M	$156.2M	-$163.0M
YoY Change	-114.07%	-196.62%	665.26%
Depreciation, Depletion And Amortization	$111.6M	$258.1M	$24.50M
YoY Change	355.42%	213.0%	690.32%
Cash From Operating Activities	$100.9M	$275.7M	$50.30M
YoY Change	100.65%	40.92%	-19.13%
INVESTING ACTIVITIES
Capital Expenditures	-$63.62M	$203.3M	-$17.00M
YoY Change	274.25%	411.4%	-20.19%
Acquisitions		$1.620B
YoY Change		110.61%
Other Investing Activities	-$202.6M	-$1.621B	-$171.6M
YoY Change	18.08%	108.98%	164.41%
Cash From Investing Activities	-$266.2M	-$1.825B	-$188.6M
YoY Change	41.17%	123.7%	118.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$278.9M
YoY Change		95.55%
Debt Paid & Issued, Net		$827.3M
YoY Change		51.11%
Cash From Financing Activities	-21.71M	1.599B	-34.10M
YoY Change	-36.33%	148.58%	-144.81%
NET CHANGE
Cash From Operating Activities	100.9M	275.7M	50.30M
Cash From Investing Activities	-266.2M	-1.825B	-188.6M
Cash From Financing Activities	-21.71M	1.599B	-34.10M
Net Change In Cash	-187.0M	49.67M	-172.4M
YoY Change	8.48%	115.15%	-431.54%
FREE CASH FLOW
Cash From Operating Activities	$100.9M	$275.7M	$50.30M
Capital Expenditures	-$63.62M	$203.3M	-$17.00M
Free Cash Flow	$164.6M	$72.37M	$67.30M
YoY Change	144.5%	-53.57%	-19.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2021-01-31#HealthCarePatientServiceMember
CY2021	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2021-01-31#HealthCarePatientServiceMember
CY2020	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#HealthCarePatientServiceMember
CY2021	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#HealthCarePatientServiceMember
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001725255
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	163560
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	124060
CY2019	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2021-01-31#HealthCarePatientServiceMember
CY2019	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#HealthCarePatientServiceMember
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2020Q3	ahco	Warrant Redemption Threshold Consecutive Trading Days WarrantRedemptionThresholdConsecutiveTradingDays	30
CY2020Q3	ahco	Business Combination Contingent Consideration Period For Measurement Of Hurdle BusinessCombinationContingentConsiderationPeriodForMeasurementOfHurdle	P10D
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-38399
CY2021	dei	Entity Registrant Name EntityRegistrantName	AdaptHealth Corp.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3677704
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	220 West Germantown Pike
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 250
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Plymouth Meeting
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19462
CY2021	dei	City Area Code CityAreaCode	610
CY2021	dei	Local Phone Number LocalPhoneNumber	424-4515
CY2021	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	2170000000
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	133908596
CY2021	dei	Auditor Name AuditorName	KPMG LLP
CY2021	dei	Trading Symbol TradingSymbol	AHCO
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Auditor Location AuditorLocation	Philadelphia, Pennsylvania
CY2021	dei	Auditor Firm AuditorFirmId	185
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	149627000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99962000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	359896000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	171065000
CY2021Q4	us-gaap	Inventory Net InventoryNet	123095000
CY2020Q4	us-gaap	Inventory Net InventoryNet	58783000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	37440000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	33441000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	670058000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	363251000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	398577000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	110468000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	147760000
CY2021Q4	us-gaap	Goodwill Goodwill	3512567000
CY2020Q4	us-gaap	Goodwill Goodwill	998810000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	202231000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	116061000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15098000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16483000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	304193000
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	208399000
CY2021Q4	us-gaap	Assets Assets	5250484000
CY2020Q4	us-gaap	Assets Assets	1813472000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	358384000
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	254212000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	15446000
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	22282000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31418000
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	20000000
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8146000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	31370000
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11043000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	43194000
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	89524000
CY2020Q4	ahco	Contingent Consideration Liability Earn Out Current ContingentConsiderationLiabilityEarnOutCurrent	36846000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	499812000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	422053000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2183552000
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	776568000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120180000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	322487000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	186470000
CY2020Q4	ahco	Contingent Consideration Liability Earn Out Noncurrent ContingentConsiderationLiabilityEarnOutNoncurrent	33631000
CY2021Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	57764000
CY2020Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	113905000
CY2021Q4	us-gaap	Liabilities Liabilities	3183795000
CY2020Q4	us-gaap	Liabilities Liabilities	1532627000
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	124060
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	163560
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2107267000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	558486000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43021000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-199196000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2354000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4411000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2061906000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	354889000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	4783000
CY2020Q4	us-gaap	Minority Interest MinorityInterest	-74044000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2066689000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	280845000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5250484000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1813472000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2454535000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1056389000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	529644000
CY2021	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	10595000
CY2020	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	14277000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2008925000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	898601000
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	440705000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	167505000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	89346000
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	56493000
CY2021	ahco	Depreciation Expense Excluding Patient Equipment Depreciation DepreciationExpenseExcludingPatientEquipmentDepreciation	63095000
CY2020	ahco	Depreciation Expense Excluding Patient Equipment Depreciation DepreciationExpenseExcludingPatientEquipmentDepreciation	11373000
CY2019	ahco	Depreciation Expense Excluding Patient Equipment Depreciation DepreciationExpenseExcludingPatientEquipmentDepreciation	3068000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2239525000
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	999320000
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	500266000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	225605000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	71346000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	29378000
CY2021	us-gaap	Interest Expense InterestExpense	95195000
CY2020	us-gaap	Interest Expense InterestExpense	41430000
CY2019	us-gaap	Interest Expense InterestExpense	39304000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20189000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5316000
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2121000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	161951000
CY2021	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	-29389000
CY2020	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	98717000
CY2019	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	2483000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-53181000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	135368000
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7650000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1832000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3444000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	318000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	190959000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-206041000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21862000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32806000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11955000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	739000
CY2021	us-gaap	Profit Loss ProfitLoss	158153000
CY2020	us-gaap	Profit Loss ProfitLoss	-194086000
CY2019	us-gaap	Profit Loss ProfitLoss	-22601000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1978000
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-32454000
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1260000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	156175000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-161632000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-21341000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126306000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52488000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22557000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133034000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52488000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22557000
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.12
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-3.08
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.95
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.67
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.08
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.95
CY2021	us-gaap	Profit Loss ProfitLoss	158153000
CY2020	us-gaap	Profit Loss ProfitLoss	-194086000
CY2019	us-gaap	Profit Loss ProfitLoss	-22601000
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	5776000
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-10667000
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	2537000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	163929000
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-204753000
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-20064000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1978000
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-32454000
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1260000
CY2021	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	5776000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-172299000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18804000
CY2018Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	102768000
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	837000
CY2019	us-gaap	Partners Capital Account Sale Of Units PartnersCapitalAccountSaleOfUnits	19163000
CY2019	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	3714000
CY2019	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	250000000
CY2019	ahco	Equity Impact Of Earn Out Contingent Consideration Liability EquityImpactOfEarnOutContingentConsiderationLiability	6833000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	19985000
CY2019	ahco	Net Income Loss Including Portion Attributable To Noncontrolling Interest Post Business Combination NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestPostBusinessCombination	-7818000
CY2019	ahco	Adjustments To Additional Paid In Capital Tax Receivable Agreement AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreement	8201000
CY2019	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	2537000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-65783000
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	123887000
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	44273000
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1338000
CY2019	us-gaap	Partners Capital Account Unit Based Compensation PartnersCapitalAccountUnitBasedCompensation	6915000
CY2019	ahco	Net Income Loss Including Portion Attributable To Noncontrolling Interest Prior To Business Combination NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestPriorToBusinessCombination	-14783000
CY2019	ahco	Stock Issued During Period Value Recapitalization StockIssuedDuringPeriodValueRecapitalization	32769000
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	124999000
CY2019	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	20000000
CY2019	ahco	Adjustments To Additional Paid In Capital Conversion Of Equity To Long Term Debt AdjustmentsToAdditionalPaidInCapitalConversionOfEquityToLongTermDebt	43500000
CY2019	ahco	Adjustments To Additional Paid In Capital Forgiveness Of Employee Loan AdjustmentsToAdditionalPaidInCapitalForgivenessOfEmployeeLoan	965000
CY2019	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	4155000
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	284000
CY2020	ahco	Warrants Exercised Value WarrantsExercisedValue	24495000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	49098000
CY2020	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	18670000
CY2020	ahco	Adjustments To Additional Paid In Capital Shares Issued In Satisfaction Of Contingent Consideration Liability Value AdjustmentsToAdditionalPaidInCapitalSharesIssuedInSatisfactionOfContingentConsiderationLiabilityValue	37556000
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	800000
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	101000
CY2020	us-gaap	Profit Loss ProfitLoss	-194086000
CY2020	ahco	Adjustments To Additional Paid In Capital Tax Receivable Agreement AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreement	24787000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-8088000
CY2020	ahco	Adjustments To Additional Paid In Capital Put Call Agreement AdjustmentsToAdditionalPaidInCapitalPutCallAgreement	-29927000
CY2020	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	-10667000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	280845000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	602661000
CY2021	ahco	Stock Options Issued During Period Value Acquisitions StockOptionsIssuedDuringPeriodValueAcquisitions	134683000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2960000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12320000
CY2021	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	25323000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	265018000
CY2021	ahco	Adjustments To Additional Paid In Capital Shares Issued In Satisfaction Of Contingent Consideration Liability Value AdjustmentsToAdditionalPaidInCapitalSharesIssuedInSatisfactionOfContingentConsiderationLiabilityValue	41088000
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1070000
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1016000
CY2021	us-gaap	Profit Loss ProfitLoss	158153000
CY2021	ahco	Adjustments To Additional Paid In Capital Tax Receivable Agreement AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreement	17617000
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2927000
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2845000
CY2019	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-11426000
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3557000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2066689000
CY2021	us-gaap	Profit Loss ProfitLoss	158153000
CY2020	us-gaap	Profit Loss ProfitLoss	-194086000
CY2019	us-gaap	Profit Loss ProfitLoss	-22601000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	258053000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	82445000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	62567000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	25323000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	18670000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	11070000
CY2021	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	-29389000
CY2020	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	98717000
CY2019	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	2483000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-53181000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	135368000
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7650000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	28624000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	22380000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21101000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	478000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5378000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1876000
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1312000
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	4054000
CY2020	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	5316000
CY2019	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	2121000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	-16135000
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3615000
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5636000
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-816000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	29694000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	29517000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20198000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14920000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19434000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1305000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2731000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10767000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9558000
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-28043000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-83383000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	136628000
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14157000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	275679000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	195634000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	60418000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1620320000
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	769337000
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	63538000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	203308000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39755000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21332000
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1125000
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8657000
CY2020	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	2046000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1824753000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	142600000
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	225000000
CY2019	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	125000000
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	13832000
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	11725000
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	837000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-815703000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84870000
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1165000000
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	591275000
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	360500000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	827271000
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	547480000
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	237572000
CY2021	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	1100000000
CY2020	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	350000000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	278850000
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	29185000
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	13049000
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	9028000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	42164000
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	39051000
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	37271000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12320000
CY2021	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	1016000
CY2020	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	101000
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1070000
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	800000
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1338000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3557000
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	59000
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	508000
CY2021	ahco	Payments For Contingent Consideration Liability And Deferred Purchase Price From Acquisitions PaymentsForContingentConsiderationLiabilityAndDeferredPurchasePriceFromAcquisitions	25233000
CY2020	ahco	Payments For Contingent Consideration Liability And Deferred Purchase Price From Acquisitions PaymentsForContingentConsiderationLiabilityAndDeferredPurchasePriceFromAcquisitions	3954000
CY2019	ahco	Payments For Contingent Consideration Liability And Deferred Purchase Price From Acquisitions PaymentsForContingentConsiderationLiabilityAndDeferredPurchasePriceFromAcquisitions	13000000
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	16135000
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	24495000
CY2020	ahco	Payments For Exchange Of Common Stock For Cash PaymentsForExchangeOfCommonStockForCash	44273000
CY2020	ahco	Payments For Exercise Of Call Option Relating To Put Call Agreement PaymentsForExerciseOfCallOptionRelatingToPutCallAgreement	29927000
CY2019	ahco	Proceeds From Issuance Of Notes Payable And Common Limited Partners Units ProceedsFromIssuanceOfNotesPayableAndCommonLimitedPartnersUnits	120000000
CY2019	ahco	Cash Acquired From Acquisition Classified As Financing Activity CashAcquiredFromAcquisitionClassifiedAsFinancingActivity	43912000
CY2019	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	23714000
CY2019	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid	250000000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1598739000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	643153000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	76144000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49665000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	23084000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	51692000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99962000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76878000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25186000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	149627000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99962000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76878000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	73630000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	35771000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	23075000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	14792000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7480000
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1318000
CY2021	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	22959000
CY2020	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	40012000
CY2019	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	36268000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	13936000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7869000
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8514000
CY2021	ahco	Assets Obtained In Exchange For Operating Lease Obligations Excluding Those Attributable To Business Combinations AssetsObtainedInExchangeForOperatingLeaseObligationsExcludingThoseAttributableToBusinessCombinations	12777000
CY2021	ahco	Operating Lease Obligation Incurred In Exchange For Operating Lease Right Of Use Assets Additions OperatingLeaseObligationIncurredInExchangeForOperatingLeaseRightOfUseAssetsAdditions	12777000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	1261200000
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	123887000
CY2021	ahco	Noncash Or Part Noncash Acquisition Contingent Purchase Price NoncashOrPartNoncashAcquisitionContingentPurchasePrice	7800000
CY2020	ahco	Noncash Or Part Noncash Acquisition Contingent Purchase Price NoncashOrPartNoncashAcquisitionContingentPurchasePrice	27064000
CY2019	ahco	Noncash Or Part Noncash Acquisition Contingent Purchase Price NoncashOrPartNoncashAcquisitionContingentPurchasePrice	12625000
CY2021	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	4478000
CY2020	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	33000
CY2019	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	1573000
CY2019	us-gaap	Notes Issued1 NotesIssued1	2000000
CY2019	ahco	Adjustments To Additional Paid In Capital Conversion Of Equity To Long Term Debt AdjustmentsToAdditionalPaidInCapitalConversionOfEquityToLongTermDebt	43500000
CY2019Q3	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0
CY2019Q4	ahco	Ownership Interest Number Of Votes Per Share OwnershipInterestNumberOfVotesPerShare	1
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">(c) Accounting Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and reported amounts of revenues and expenses during the reporting period. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements and other factors that management believes to be reasonable. Significant areas requiring the use of management estimates relate to revenue </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">recognition and the valuation of accounts receivable (implicit price concession), income taxes, contingent consideration, equity-based compensation, interest rate swaps, warrant liability and long-lived assets, including goodwill and identifiable intangible assets. Actual results could differ from those estimates.</p>
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2454535000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1056389000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	529644000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2454535000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1056389000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	529644000
CY2021Q4	ahco	Cares Act Recoupable Advance Payment Deferrals CaresActRecoupableAdvancePaymentDeferrals	12800000
CY2021	ahco	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCaresAct	8600000
CY2022Q1	ahco	Payment Of Deferred Employment Tax PaymentOfDeferredEmploymentTax	4300000
CY2021Q4	ahco	Liability For Social Security Taxes Deferred Cares Act Current LiabilityForSocialSecurityTaxesDeferredCaresActCurrent	4300000
CY2021Q4	ahco	Liability For Social Security Taxes Deferred Cares Act Noncurrent LiabilityForSocialSecurityTaxesDeferredCaresActNoncurrent	4300000
CY2021Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	23800000
CY2020Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	20200000
CY2020Q2	ahco	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	17200000
CY2021Q4	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	10600000
CY2020Q4	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	14300000
CY2020Q2	ahco	Cares Act Recoupable Advance Payment CaresActRecoupableAdvancePayment	45800000
CY2021	ahco	Cares Act Recoupment Of Advance Payment CaresActRecoupmentOfAdvancePayment	36700000
CY2021Q4	us-gaap	Cash Cash	149613000
CY2020Q4	us-gaap	Cash Cash	94360000
CY2021Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	14000
CY2020Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	5602000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	149627000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99962000
CY2021	us-gaap	Lease Practical Expedients Package LeasePracticalExpedientsPackage	true
CY2021	us-gaap	Advertising Expense AdvertisingExpense	18500000
CY2020	us-gaap	Advertising Expense AdvertisingExpense	5300000
CY2019	us-gaap	Advertising Expense AdvertisingExpense	2100000
CY2021	us-gaap	Cost Direct Material CostDirectMaterial	955813000
CY2020	us-gaap	Cost Direct Material CostDirectMaterial	441931000
CY2019	us-gaap	Cost Direct Material CostDirectMaterial	156430000
CY2021	us-gaap	Cost Direct Labor CostDirectLabor	595668000
CY2020	us-gaap	Cost Direct Labor CostDirectLabor	257898000
CY2019	us-gaap	Cost Direct Labor CostDirectLabor	153173000
CY2021	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	194958000
CY2020	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	71072000
CY2019	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	59498000
CY2021	us-gaap	Occupancy Net OccupancyNet	48586000
CY2020	us-gaap	Occupancy Net OccupancyNet	22344000
CY2019	us-gaap	Occupancy Net OccupancyNet	13407000
CY2021	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	204573000
CY2020	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	93054000
CY2019	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	57339000
CY2021	ahco	Share Based Compensation Expense Direct Cost ShareBasedCompensationExpenseDirectCost	7301000
CY2020	ahco	Share Based Compensation Expense Direct Cost ShareBasedCompensationExpenseDirectCost	7845000
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	2026000
CY2020	us-gaap	Severance Costs1 SeveranceCosts1	4457000
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	858000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	2008925000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	898601000
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	440705000
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	60100000
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	35800000
CY2019	us-gaap	Labor And Related Expense LaborAndRelatedExpense	31700000
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">(w) Concentration of Credit Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and trade accounts receivable. The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents. As of December 31, 2021, and 2020, less than 10% of the Company’s net accounts receivable are from patients under co-pay or private plan arrangements. Credit evaluations, account monitoring procedures and a third-party collection agent are utilized to minimize the risk of loss. Collateral is not required.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Cost-containment efforts of governmental organizations, primarily Medicare, could have a material adverse effect on the Company’s net revenue and profitability. Medicare typically awards contracts on a category-by-category basis through a competitive bidding process. Bids are generally solicited from multiple distributors with intention of driving down pricing. All Medicare Durable Medical Equipment, Prosthetics, Orthotics, & Supplies (“DMEPOS”) Competitive Bidding Program contracts expired on December 31, 2018, and, as a result, there is a temporary gap in the entire DMEPOS Competitive Bidding Program that CMS stated would last until December 31, 2020 and be replaced by a single round of competition named “Round 2021” which consolidated the competitive bidding areas (“CBAs”) included in the Round 1 2017 and Round 2 Recompete DMEPOS Competitive Bidding Programs. Round 2021 contracts became effective on January 1, 2021 and extend through December 31, 2023. CMS included 16 product categories in </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Round 2021. On April 10, 2020, CMS announced that due to the COVID-19 pandemic, it removed the non-invasive ventilators product category from the Round 2021 DMEPOS Competitive Bidding Program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On October 27, 2020, CMS announced that it would not award competitive bid contracts in 13 of the 15 remaining product categories due to a failure to achieve expected savings, and that contract awards would only be made for off-the-shelf (“OTS”) knee and back braces. For the years ended December 31, 2021, 2020 and 2019, net revenue generated with respect to providing OTS knee and back braces (excluding amounts generated in non-rural and rural non-bid areas) were not material. The Company expects to obtain contracts for OTS knee and back braces, and does not expect the single payment amounts imposed by CMS under such contracts to have a material impact on the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The competitive bidding process (which is expected to be re-bid every three years) has historically put pressure on the amount the Company is reimbursed in the markets in which it exists, as well as in areas that are not subject to the DMEPOS Competitive Bidding Program. The rates required to win future competitive bids could continue to depress reimbursement rates. The Company will continue to monitor developments regarding the DMEPOS Competitive Bidding Program. While the Company cannot predict the outcome of the DMEPOS Competitive Bidding Program on its business in the future nor the Medicare payment rates that will be in effect in future years for the items subjected to competitive bidding, the program may materially adversely affect its financial condition and results of operations.</p>
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	1657970000
CY2021	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	1261200000
CY2021	ahco	Business Combination Contingent Consideration BusinessCombinationContingentConsideration	7800000
CY2021	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	4478000
CY2021	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	2931448000
CY2019	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustments Related To Previous Period BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod	800000
CY2019	ahco	Goodwill Gross Receipt Of Prior Escrow Payment GoodwillGrossReceiptOfPriorEscrowPayment	500000
CY2019	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	128844
CY2021	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	266492
CY2020	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	229036
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2863840
CY2020	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2650051
CY2019	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2292523
CY2021	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	1005097000
CY2020	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	427352000
CY2019	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	52711000
CY2021	us-gaap	Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual	136404000
CY2020	us-gaap	Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual	17673000
CY2019	us-gaap	Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual	7856000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	202231000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	116061000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	620181000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	192417000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	221604000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	81949000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	398577000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	110468000
CY2021	us-gaap	Depreciation Depreciation	211500000
CY2020	us-gaap	Depreciation Depreciation	76400000
CY2019	us-gaap	Depreciation Depreciation	62600000
CY2021	ahco	Property Plant And Equipment Fully Depreciated Assets Written Off PropertyPlantAndEquipmentFullyDepreciatedAssetsWrittenOff	71900000
CY2020	ahco	Property Plant And Equipment Fully Depreciated Assets Written Off PropertyPlantAndEquipmentFullyDepreciatedAssetsWrittenOff	62600000
CY2019	ahco	Property Plant And Equipment Fully Depreciated Assets Written Off PropertyPlantAndEquipmentFullyDepreciatedAssetsWrittenOff	72800000
CY2019Q4	us-gaap	Goodwill Goodwill	266791000
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	732019000
CY2020Q4	us-gaap	Goodwill Goodwill	998810000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2536566000
CY2021	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred	-657000
CY2021	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-22152000
CY2021Q4	us-gaap	Goodwill Goodwill	3512567000
CY2021	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-22200000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46500000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6000000.0
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	866000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	39881000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	32513000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	22176000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	21228000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	19163000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	67270000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	202231000
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	33540000
CY2021	ahco	Contingent Consideration Liability Additions ContingentConsiderationLiabilityAdditions	7800000
CY2021	ahco	Payment For Contingent Consideration Liability PaymentForContingentConsiderationLiability	20347000
CY2021	ahco	Business Combination Contingent Consideration Liability Other Activity BusinessCombinationContingentConsiderationLiabilityOtherActivity	173000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	20300000
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	14725000
CY2020	ahco	Contingent Consideration Liability Additions ContingentConsiderationLiabilityAdditions	27064000
CY2020	ahco	Payment For Contingent Consideration Liability PaymentForContingentConsiderationLiability	4204000
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4176000
CY2020	ahco	Business Combination Contingent Consideration Liability Other Activity BusinessCombinationContingentConsiderationLiabilityOtherActivity	131000
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	33540000
CY2021Q4	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	800000
CY2020Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	250000000
CY2021Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	250000000
CY2021	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	2900000
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-7800000
CY2020	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	2800000
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3500000
CY2019	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	900000
CY2019	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-12400000
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	13710000
CY2019Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	7853000
CY2021	ahco	Capitalized Fees Deferred Finance Costs CapitalizedFeesDeferredFinanceCosts	29185000
CY2020	ahco	Capitalized Fees Deferred Finance Costs CapitalizedFeesDeferredFinanceCosts	13049000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5378000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1876000
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	4054000
CY2020	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	5316000
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	33463000
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	13710000
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	33500000
CY2021Q4	ahco	Deferred Financing Costs Expected Amortization Year One DeferredFinancingCostsExpectedAmortizationYearOne	5234000
CY2021Q4	ahco	Deferred Financing Costs Expected Amortization Year Two DeferredFinancingCostsExpectedAmortizationYearTwo	5234000
CY2021Q4	ahco	Deferred Financing Costs Expected Amortization Year Three DeferredFinancingCostsExpectedAmortizationYearThree	5234000
CY2021Q4	ahco	Deferred Financing Costs Expected Amortization Year Four DeferredFinancingCostsExpectedAmortizationYearFour	5147000
CY2021Q4	ahco	Deferred Financing Costs Expected Amortization Year Five DeferredFinancingCostsExpectedAmortizationYearFive	3659000
CY2021Q4	ahco	Deferred Financing Costs Expected Amortization After Year Five DeferredFinancingCostsExpectedAmortizationAfterYearFive	8955000
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	33463000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	248027000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	191038000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	34370000
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26705000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	30103000
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	11062000
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	45884000
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	25407000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	358384000
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	254212000
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	31448000
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	12557000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2203552000
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	784714000
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	20000000
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8146000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2183552000
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	776568000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	97900000
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	42000000.0
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	27800000
CY2019Q1	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	250000000
CY2019Q1	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	3700000
CY2019Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	9000000.0
CY2019Q1	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	2100000
CY2020Q4	ahco	Put Call Option And Consent Agreement Number Of Shares Comprising Consideration Unit PutCallOptionAndConsentAgreementNumberOfSharesComprisingConsiderationUnit	1
CY2020Q4	ahco	Number Of Shares Potentially Put Or Called NumberOfSharesPotentiallyPutOrCalled	1898967
CY2020Q4	ahco	Shares Put Agreement Minimum Variable Price SharesPutAgreementMinimumVariablePrice	0.85
CY2020Q4	ahco	Number Of Shares Potentially Put Or Called NumberOfSharesPotentiallyPutOrCalled	1898967
CY2020Q4	ahco	Shares Call Agreement Price SharesCallAgreementPrice	15.76
CY2020	ahco	Adjustments To Additional Paid In Capital Put Call Agreement AdjustmentsToAdditionalPaidInCapitalPutCallAgreement	-29900000
CY2020Q4	ahco	Number Of Shares Potentially Put Or Called NumberOfSharesPotentiallyPutOrCalled	1898967
CY2020Q4	ahco	Adjustments To Additional Paid In Capital Put Call Agreement AdjustmentsToAdditionalPaidInCapitalPutCallAgreement	29900000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	20000000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	35000000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	40000000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	40000000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	650000000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1450000000
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2235000000
CY2019Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	1
CY2021Q1	ahco	Shares Issued During Period Shares Shares Exchanged SharesIssuedDuringPeriodSharesSharesExchanged	13218758
CY2021Q1	ahco	Shares Issued During Period Value Shares Exchanged SharesIssuedDuringPeriodValueSharesExchanged	77900000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	ahco	Number Of Votes Per Share NumberOfVotesPerShare	1
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	245000000
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Limited Partners Units ProceedsFromIssuanceOfCommonLimitedPartnersUnits	20000000.0
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	12666666
CY2019Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021	ahco	Warrants Exercised In Cashless Transaction Number Of Warrants WarrantsExercisedInCashlessTransactionNumberOfWarrants	224121
CY2021	ahco	Cashless Exercise Of Warrants Shares CashlessExerciseOfWarrantsShares	118379
CY2020	ahco	Warrants Exercised In Cashless Transaction Number Of Warrants WarrantsExercisedInCashlessTransactionNumberOfWarrants	6254803
CY2020	ahco	Warrants Exercised For Cash Number Of Warrants WarrantsExercisedForCashNumberOfWarrants	2131315
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	24500000
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4056427
CY2018Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	19985000
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7650000
CY2019Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	27635000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	135368000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	49098000
CY2020Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	113905000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-53181000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2960000
CY2021Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	57764000
CY2020Q3	ahco	Warrant Redemption Price WarrantRedemptionPrice	0.01
CY2020Q3	ahco	Warrant Redemption Stock Price Trigger WarrantRedemptionStockPriceTrigger	18.00
CY2020Q3	ahco	Warrant Redemption Threshold Trading Days WarrantRedemptionThresholdTradingDays	20
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2020Q3	ahco	Warrant Cashless Exercise Share Equivalent Of Exercise Price WarrantCashlessExerciseShareEquivalentOfExercisePrice	0.6144
CY2020Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	0.3856
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2020Q3	us-gaap	Share Price SharePrice	18.7175
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2020	ahco	Public Warrants Number Redeemed PublicWarrantsNumberRedeemed	2285410
CY2020	ahco	Warrants Exercise Shares WarrantsExerciseShares	881239
CY2020	ahco	Business Combination Contingent Consideration Shares Authorized Per Installment BusinessCombinationContingentConsiderationSharesAuthorizedPerInstallment	1000000
CY2021	ahco	Business Combination Contingent Consideration Shares Authorized Per Installment BusinessCombinationContingentConsiderationSharesAuthorizedPerInstallment	1000000
CY2021	ahco	Business Combination Contingent Consideration Stock Price Hurdle Second Measurement Date BusinessCombinationContingentConsiderationStockPriceHurdleSecondMeasurementDate	18
CY2020	ahco	Business Combination Contingent Consideration Stock Price Hurdle Second Measurement Date BusinessCombinationContingentConsiderationStockPriceHurdleSecondMeasurementDate	15
CY2021	ahco	Share Price Average SharePriceAverage	18
CY2020	ahco	Share Price Average SharePriceAverage	15
CY2020	ahco	Business Combination Contingent Consideration Number Of Shares Issued During Period BusinessCombinationContingentConsiderationNumberOfSharesIssuedDuringPeriod	1000000
CY2021	ahco	Business Combination Contingent Consideration Number Of Shares Issued During Period BusinessCombinationContingentConsiderationNumberOfSharesIssuedDuringPeriod	1000000
CY2020	ahco	Business Combination Contingent Consideration Shares Authorized Per Installment BusinessCombinationContingentConsiderationSharesAuthorizedPerInstallment	1000000
CY2021	ahco	Business Combination Contingent Consideration Shares Authorized Per Installment BusinessCombinationContingentConsiderationSharesAuthorizedPerInstallment	1000000
CY2022Q4	ahco	Business Combination Contingent Consideration Stock Price Hurdle Third Measurement Date BusinessCombinationContingentConsiderationStockPriceHurdleThirdMeasurementDate	22
CY2018Q4	ahco	Earn Out Contingent Liability EarnOutContingentLiability	6833000
CY2019	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	2483000
CY2019Q4	ahco	Earn Out Contingent Liability EarnOutContingentLiability	9316000
CY2020	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	98717000
CY2020	ahco	Adjustments To Additional Paid In Capital Shares Issued In Satisfaction Of Contingent Consideration Liability Value AdjustmentsToAdditionalPaidInCapitalSharesIssuedInSatisfactionOfContingentConsiderationLiabilityValue	37556000
CY2020Q4	ahco	Earn Out Contingent Liability EarnOutContingentLiability	70477000
CY2021	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	-29389000
CY2021	ahco	Adjustments To Additional Paid In Capital Shares Issued In Satisfaction Of Contingent Consideration Liability Value AdjustmentsToAdditionalPaidInCapitalSharesIssuedInSatisfactionOfContingentConsiderationLiabilityValue	41088000
CY2020	ahco	Business Combination Contingent Consideration Number Of Shares Issued During Period BusinessCombinationContingentConsiderationNumberOfSharesIssuedDuringPeriod	1000000
CY2021	ahco	Business Combination Contingent Consideration Number Of Shares Issued During Period BusinessCombinationContingentConsiderationNumberOfSharesIssuedDuringPeriod	1000000
CY2021	ahco	Business Combination Contingent Consideration Remaining Shares Reclassified To Stockholders Equity BusinessCombinationContingentConsiderationRemainingSharesReclassifiedToStockholdersEquity	1000000
CY2021	ahco	Adjustments To Additional Paid In Capital Contingent Consideration Remaining Shares Reclassified To Stockholders Equity AdjustmentsToAdditionalPaidInCapitalContingentConsiderationRemainingSharesReclassifiedToStockholdersEquity	16600000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	703170
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P5Y
CY2021Q1	ahco	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	6900000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3416666
CY2019Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.50
CY2019Q4	ahco	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	7200000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	47335
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.25
CY2020Q2	ahco	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	300000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3464001
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3417000
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.50
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3417000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.50
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	47000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.25
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3464000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.56
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1447000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.16
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	914000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.66
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5766000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.26
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2021	ahco	Stock Issued During Period Shares Stock Options Exercised Cash Basis StockIssuedDuringPeriodSharesStockOptionsExercisedCashBasis	1138982
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12300000
CY2021	ahco	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Cashless Basis ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessBasis	307613
CY2021	ahco	Stock Issued During Period Stock Options Exercised Cashless Basis Shares StockIssuedDuringPeriodStockOptionsExercisedCashlessBasisShares	133126
CY2019	ahco	Stock Issued During Period Shares Stock Options Exercised Cash Basis StockIssuedDuringPeriodSharesStockOptionsExercisedCashBasis	0
CY2020	ahco	Stock Issued During Period Shares Stock Options Exercised Cash Basis StockIssuedDuringPeriodSharesStockOptionsExercisedCashBasis	0
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25300000
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4600000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18700000
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2100000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11100000
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	2700000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	2200000
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	39600000
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2021	us-gaap	Net Income Loss NetIncomeLoss	156175000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-161632000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-21341000
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	14379000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	141796000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-161632000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21341000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-53181000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	88615000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-161632000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-21341000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126306000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52488000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22557000
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2377000
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3782000
CY2021	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	569000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133034000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52488000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22557000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.12
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.08
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.95
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.67
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.08
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.95
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12808000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16177000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	226000
CY2021	ahco	Antidilutive Securities Excluded From Computation Of Earnings Per Share Business Combination Contingent Consideration Shares Authorized Per Installment AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareBusinessCombinationContingentConsiderationSharesAuthorizedPerInstallment	1000000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	147760000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	17410000
CY2021Q4	ahco	Right Of Use Assets Total RightOfUseAssetsTotal	165170000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31418000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120180000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	151598000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	15446000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	132000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	15578000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	37043000
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	33689000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	19905000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	14030000
CY2021	us-gaap	Sublease Income SubleaseIncome	1239000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	36216000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	15505000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	31011000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	145000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	25701000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	21419000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	14558000
CY2021Q4	ahco	Lessee Operating Lease Liability Payments Due Year Five And After Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive	45267000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	174172000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	15650000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	22574000
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	72000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	151598000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	15578000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	18403000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	14893000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	11788000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	9055000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5960000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	15646000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	75745000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	1900000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	36510000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	42164000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	91420000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	22959000
CY2021	ahco	Number Of Plans Administered By Others NumberOfPlansAdministeredByOthers	2
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2900000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1500000
CY2021	ahco	Minimum Loss For Claim Under Medical Stop Loss Insurance MinimumLossForClaimUnderMedicalStopLossInsurance	225000
CY2019	ahco	Minimum Loss For Claim Under Medical Stop Loss Insurance MinimumLossForClaimUnderMedicalStopLossInsurance	175000
CY2020	ahco	Minimum Loss For Claim Under Medical Stop Loss Insurance MinimumLossForClaimUnderMedicalStopLossInsurance	175000
CY2021Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	11700000
CY2020Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	3500000
CY2018Q2	ahco	Number Of Subsidiaries Participating In Agreement NumberOfSubsidiariesParticipatingInAgreement	1
CY2018Q2	ahco	Agreement Term AgreementTerm	P5Y
CY2021Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	5100000
CY2021Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	5100000
CY2021	ahco	Number Of Executives NumberOfExecutives	1
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2356000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5608000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-961000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8070000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3538000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1222000
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	10426000
CY2020	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	9146000
CY2019	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	261000
CY2020	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-21101000
CY2019	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	478000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32806000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11955000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	739000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	22891000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-16587000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	371000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-511000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4514000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	107000
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	22380000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.252
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.031
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.047
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.033
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.019
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.004
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.035
CY2021	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	0.059
CY2020	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	0.171
CY2019	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	0.091
CY2021	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Nondeductible Contingent Consideration EffectiveIncomeTaxRateReconciliationChangeInFairValueOfNondeductibleContingentConsideration	-0.012
CY2020	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Nondeductible Contingent Consideration EffectiveIncomeTaxRateReconciliationChangeInFairValueOfNondeductibleContingentConsideration	-0.044
CY2019	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Nondeductible Contingent Consideration EffectiveIncomeTaxRateReconciliationChangeInFairValueOfNondeductibleContingentConsideration	-0.011
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.017
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.098
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.017
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.003
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.010
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.172
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.058
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.034
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	51115000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	4276000
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	291331000
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3920000
CY2021Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	4218000
CY2020Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	178978000
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	561000
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	24000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	6845000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	693000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	32926000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12454000
CY2021Q4	ahco	Deferred Tax Assets Start Up Organizational Costs DeferredTaxAssetsStartUpOrganizationalCosts	7580000
CY2020Q4	ahco	Deferred Tax Assets Start Up Organizational Costs DeferredTaxAssetsStartUpOrganizationalCosts	475000
CY2021Q4	ahco	Deferred Tax Assets Contract Liabilities DeferredTaxAssetsContractLiabilities	3041000
CY2020Q4	ahco	Deferred Tax Assets Contract Liabilities DeferredTaxAssetsContractLiabilities	255000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3801000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	558000
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	563000
CY2021Q4	ahco	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	40683000
CY2021Q4	ahco	Deferred Income Tax Assets Contingent Consideration DeferredIncomeTaxAssetsContingentConsideration	3541000
CY2020Q4	ahco	Deferred Income Tax Assets Contingent Consideration DeferredIncomeTaxAssetsContingentConsideration	9978000
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	817000
CY2020Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	813000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	446459000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	212987000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1812000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1536000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	444647000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	211451000
CY2021Q4	ahco	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	39760000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	100694000
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3052000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	140454000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3052000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	304193000
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	208399000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1800000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1500000
CY2021Q4	ahco	Operating Loss Carryforward Expected To Expire Unused OperatingLossCarryforwardExpectedToExpireUnused	3400000
CY2021Q4	ahco	Operating Loss Carryforwards Not Subject To Expiration OperatingLossCarryforwardsNotSubjectToExpiration	134400000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	1947000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1947000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	2100000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4047000
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	900000
CY2020Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	900000
CY2019Q4	ahco	Shares Issued During Period Shares Shares Exchanged SharesIssuedDuringPeriodSharesSharesExchanged	3480466
CY2019Q4	ahco	Tax Deductible Goodwill Basis Step Up TaxDeductibleGoodwillBasisStepUp	33600000
	ahco	Shares Issued During Period Shares Shares Exchanged SharesIssuedDuringPeriodSharesSharesExchanged	31936305
	ahco	Tax Deductible Goodwill Basis Step Up TaxDeductibleGoodwillBasisStepUp	1029600000
CY2021	ahco	Tax Deductible Goodwill Basis Step Up TaxDeductibleGoodwillBasisStepUp	537900000
CY2020	ahco	Tax Deductible Goodwill Basis Step Up TaxDeductibleGoodwillBasisStepUp	485700000
CY2019	ahco	Tax Deductible Goodwill Basis Step Up TaxDeductibleGoodwillBasisStepUp	6000000.0
CY2021	ahco	Shares Issued During Period Shares Shares Exchanged SharesIssuedDuringPeriodSharesSharesExchanged	13218758
CY2020	ahco	Shares Issued During Period Shares Shares Exchanged SharesIssuedDuringPeriodSharesSharesExchanged	18167547
CY2019	ahco	Shares Issued During Period Shares Shares Exchanged SharesIssuedDuringPeriodSharesSharesExchanged	550000
CY2019Q4	ahco	Tax Receivable Agreement Percentage Savings Payable TaxReceivableAgreementPercentageSavingsPayable	0.85
CY2019Q4	ahco	Tax Receivable Agreement Percentage Savings Payable TaxReceivableAgreementPercentageSavingsPayable	0.85
CY2021	ahco	Liability For Payments Under Tax Receivable Agreement Increase Due To Shares Exchanged LiabilityForPaymentsUnderTaxReceivableAgreementIncreaseDueToSharesExchanged	146500000
CY2020	ahco	Liability For Payments Under Tax Receivable Agreement Increase Due To Shares Exchanged LiabilityForPaymentsUnderTaxReceivableAgreementIncreaseDueToSharesExchanged	140400000
CY2021	ahco	Deferred Tax Asset Attributable To Tax Receivable Agreement Increase Decrease DeferredTaxAssetAttributableToTaxReceivableAgreementIncreaseDecrease	164100000
CY2020	ahco	Deferred Tax Asset Attributable To Tax Receivable Agreement Increase Decrease DeferredTaxAssetAttributableToTaxReceivableAgreementIncreaseDecrease	165200000
CY2021	ahco	Liability For Payments Under Tax Receivable Agreement LiabilityForPaymentsUnderTaxReceivableAgreement	300300000
CY2020	ahco	Liability For Payments Under Tax Receivable Agreement LiabilityForPaymentsUnderTaxReceivableAgreement	152000000.0

Files In Submission

Name	View Source	Status
0001558370-22-002603-index-headers.html	Edgar Link	pending
0001558370-22-002603-index.html	Edgar Link	pending
0001558370-22-002603.txt	Edgar Link	pending
0001558370-22-002603-xbrl.zip	Edgar Link	pending
ahco-20211231.xsd	Edgar Link	pending
ahco-20211231x10k.htm	Edgar Link	pending
ahco-20211231x10k_htm.xml	Edgar Link	completed
ahco-20211231xex21d1.htm	Edgar Link	pending
ahco-20211231xex23d1.htm	Edgar Link	pending
ahco-20211231xex31d1.htm	Edgar Link	pending
ahco-20211231xex31d2.htm	Edgar Link	pending
ahco-20211231xex32.htm	Edgar Link	pending
ahco-20211231_cal.xml	Edgar Link	unprocessable
ahco-20211231_def.xml	Edgar Link	unprocessable
ahco-20211231_lab.xml	Edgar Link	unprocessable
ahco-20211231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHCO
AdaptHealth Corp. Stock $ahco

2021 Q4 Form 10-K Financial Statement

#000155837022002603 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHCO AdaptHealth Corp. Stock $ahco

2021 Q4 Form 10-K Financial Statement

#000155837022002603 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHCO
AdaptHealth Corp. Stock $ahco